These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8095649)

  • 41. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
    AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
    Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS
    Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
    Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma.
    Am J Health Syst Pharm; 1996 Jul; 53(13):1500, 1505. PubMed ID: 8809269
    [No Abstract]   [Full Text] [Related]  

  • 46. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma.
    Presant CA; Scolaro M; Kennedy P; Blayney DW; Flanagan B; Lisak J; Presant J
    Lancet; 1993 May; 341(8855):1242-3. PubMed ID: 8098393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KS update.
    Notes Undergr; 1995; (no 29):4. PubMed ID: 11362282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Kaposi's sarcoma with liposomal doxorubicin.
    Bergin C; O'Leary A; McCreary C; Sabra K; Mulcahy F
    Am J Health Syst Pharm; 1995 Sep; 52(18):2001-4. PubMed ID: 8528867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of AIDS and its attendant malignancies.
    Volberding PA; Kaplan LD
    Prog Clin Biol Res; 1989; 288():459-70. PubMed ID: 2654959
    [No Abstract]   [Full Text] [Related]  

  • 51. Liposomal doxorubicin.
    Linsky KF; Ignoffo RJ
    Cancer Pract; 1996; 4(5):288-90. PubMed ID: 9004577
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pulmonary Kaposi's sarcoma in a heterosexual parenteral drug addict patient with the acquired immunodeficiency syndrome].
    Grocín AI; Goya MA; Arrizabalaga J; Iribarren JA; Rodríguez-Arrondo F; Tuneu A; Lobo C
    Med Clin (Barc); 1991 Oct; 97(13):500-2. PubMed ID: 1721989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early approval for two lipid-based drugs.
    Baker R
    BETA; 1995 Dec; ():4. PubMed ID: 11363009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete remission of a case of classical Kaposi's sarcoma with liposomal doxorubicin and radiotherapy.
    Ezquerra GM; Redonnet MS; Cuchillero RO; Millet PU
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):901-2. PubMed ID: 16898935
    [No Abstract]   [Full Text] [Related]  

  • 55. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
    Gill PS; Espina BM; Muggia F; Cabriales S; Tulpule A; Esplin JA; Liebman HA; Forssen E; Ross ME; Levine AM
    J Clin Oncol; 1995 Apr; 13(4):996-1003. PubMed ID: 7707129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Liposomal adriamycin: preparation, administration, and toxicity monitoring. Nursing aspects].
    Panzolini S
    Suppl Tumori; 2004; 3(4):S120. PubMed ID: 15206235
    [No Abstract]   [Full Text] [Related]  

  • 57. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
    Gabizon A; Martin F
    Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.
    Tulpule A; Yung RC; Wernz J; Espina BM; Myers A; Scadden DT; Cabriales S; Ilaw M; Boswell W; Gill PS
    J Clin Oncol; 1998 Oct; 16(10):3369-74. PubMed ID: 9779714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.